tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX

Neurocrine (NBIX) Technical Analysis

1,178 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Neurocrine’s (NBIX) Moving Averages Convergence Divergence (MACD) indicator is 0.64, suggesting Neurocrine is a Buy.
Neurocrine’s (NBIX) 20-Day exponential moving average is 138.67, while Neurocrine’s (NBIX) share price is $139.44, making it a Buy.
Neurocrine’s (NBIX) 50-Day exponential moving average is 136.38, while Neurocrine’s (NBIX) share price is $139.44, making it a Buy.

Neurocrine (NBIX) Pivot Points

Apr 28, 2024, 05:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
133.00
134.51
136.72
138.23
140.44
141.95
144.16
Fibonacci
134.51
135.93
136.81
138.23
139.65
140.53
141.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurocrine (NBIX) Moving Averages

Apr 28, 2024, 05:56 AM
Period
Simple
Exponential
MA5
138.26Buy
138.83Buy
MA10
138.98Buy
138.96Buy
MA20
139.62Sell
138.67Buy
MA50
137.30Buy
136.38Buy
MA100
130.66Buy
130.95Buy
MA200
118.59Buy
119.97Buy
Neurocrine’s (NBIX) 10-Day exponential moving average is 138.96, while Neurocrine’s (NBIX) share price is $139.44, making it a Buy.
Neurocrine’s (NBIX) 100-Day exponential moving average is 130.95, while Neurocrine’s (NBIX) share price is $139.44, making it a Buy.
Neurocrine’s (NBIX) stock price is $139.44 and Neurocrine’s (NBIX) 50-day simple moving average is 137.30, creating a Buy signal.
Neurocrine’s (NBIX) stock price is $139.44 and Neurocrine’s (NBIX) 100-day simple moving average is 130.66, creating a Buy signal.
Neurocrine’s (NBIX) stock price is $139.44 and Neurocrine’s (NBIX) 200-day simple moving average is 118.59, creating a Buy signal.

Neurocrine (NBIX) Technical Indicators

Apr 28, 2024, 05:56 AM
Name
Value
Implied Action
RSI (14)
52.92
Neutral
STOCH (9,6)
54.81
Neutral
STOCHRSI (14)
35.01
Neutral
MACD (12,26)
0.64
Buy
ADX (14)
14.92
Buy
Williams %R
-59.75
Buy
CCI (14)
-35.29
Neutral
ATR (14)
3.99
-
Ultimate Oscillator
54.70
Neutral
ROC
0.00
-
Neurocrine’s (NBIX) Relative Strength Index (RSI) is 52.92, creating a Neutral signal.
Neurocrine’s (NBIX) Trend Strength Indicator (ADX) is 14.92, creating a Buy signal.
Neurocrine’s (NBIX) Commodity Channel Index (CCI) is -35.29, creating a Neutral signal.

FAQ

Is NBIX a Buy, Hold, or Sell?
Based on NBIX’s technical indicators, NBIX is a Strong Buy.
    What is NBIX’s RSI (14)?
    NBIX’s RSI (14) is 52.92, which suggests NBIX is a Neutral.
      What is NBIX’s MACD?
      NBIX’s MACD is 0.64, which suggests NBIX is a Buy.
        What is NBIX’s 5-day moving average?
        NBIX’s 5-day moving average is 138.26, which suggests NBIX is a Buy.
          What is NBIX’s 20-day moving average?
          NBIX 20-day moving average is 139.62, which suggests NBIX is a Sell.
            What is NBIX’s 50-day moving average?
            NBIX’s 50-day moving average is 137.30, which suggests NBIX is a Buy.
              What is NBIX’s 200-day moving average?
              NBIX’s 200-day moving average is 118.59, which suggests NBIX is a Buy.
                What is NBIX’s Williams % R (14)?
                NBIX’s Williams % R (14) is -59.75, which suggests NBIX is a Buy.
                  What is NBIX’s CCI (14)?
                  NBIX’s CCI (14) is -35.29, which suggests NBIX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis